최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한소화기학회지 = The Korean journal of gastroenterology, v.81 no.3, 2023년, pp.109 - 120
Jeong, Han Taek (Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea) , Bae, June Hwa (Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea) , Kim, Ho Gak (Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea) , Han, Jimin (Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea)
초록이 없습니다.
Sung, Hyuna, Ferlay, Jacques, Siegel, Rebecca L., Laversanne, Mathieu, Soerjomataram, Isabelle, Jemal, Ahmedin, Bray, Freddie. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, vol.71, no.3, 209-249.
Jung, Kyu-Won, Won, Young-Joo, Kang, Mee Joo, Kong, Hyun-Joo, Im, Jeong-Soo, Seo, Hong Gwan. Prediction of Cancer Incidence and Mortality in Korea, 2022. Cancer research and treatment : official journal of Korean Cancer Association, vol.54, no.2, 345-351.
Sung, Min Je, Bang, Seungmin. Updates of Chemotherapy and Radiotherapy for Pancreatic Cancer. The Korean journal of pancreas and biliary tract = 대한췌담도학회지, vol.25, no.2, 72-82.
Frere, Corinne. Burden of venous thromboembolism in patients with pancreatic cancer. World journal of gastroenterology : WJG, vol.27, no.19, 2325-2340.
Berger, Anne Katrin, Singh, Hans Martin, Werft, Wiebke, Muckenhuber, Alexander, Sprick, Martin R., Trumpp, Andreas, Weichert, Wilko, Jäger, Dirk, Springfeld, Christoph. High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer under palliative chemotherapy: A retrospective cohort study. Pancreatology : official journal of the International Association of Pancreatology ... [et al.], vol.17, no.4, 629-634.
Lyman, Gary H., Eckert, Laurent, Wang, Yanxin, Wang, Hongwei, Cohen, Alexander. Venous Thromboembolism Risk in Patients With Cancer Receiving Chemotherapy: A Real-World Analysis. The oncologist, vol.18, no.12, 1321-1329.
García Adrián, Silvia, González, Adán Rodríguez, de Castro, Eva Martínez, Olmos, Vanessa Pachón, Morán, Laura Ortega, del Prado, Purificación Martínez, Fernández, Mercedes Salgado, Burón, José David Cumplido, Escobar, Ignacio García, Galán, Joaquina Martínez, Pérez, Ana Isabel Ferrer, Neria, Fernando, Lavin, Diego Cacho, Hernández, Borja López de San Vicente, Jiménez-Fonseca, Paula, Muñoz Martín, Andrés J.. Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis. European journal of internal medicine, vol.105, 30-37.
Hanna-Sawires, Randa G., Groen, Jesse V., Hamming, Alexander, Tollenaar, Rob A.E.M., Mesker, Wilma E., Luelmo, Saskia A.C., Vahrmeijer, Alexander L., Bonsing, Bert A., Versteeg, Henri H., Klok, F.A., Mieog, J.Sven D.. Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer. Thrombosis research, vol.207, 134-139.
Barrau, Mathilde, Maoui, Khawla, Le Roy, Bertrand, Roblin, Xavier, Mismetti, Patrick, Phelip, Jean-Marc, Williet, Nicolas. Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma. Journal of cancer research and clinical oncology, vol.147, no.11, 3447-3454.
Kruger, S., Haas, M., Burkl, C., Goehring, P., Kleespies, A., Roeder, F., Gallmeier, E., Ormanns, S., Westphalen, C.B., Heinemann, V., Rank, A., Boeck, S.. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study. Thrombosis research, vol.157, 9-15.
Suzuki, Takahito, Hori, Reina, Takeuchi, Kazutaka, Yamamura, Ryo, Katoh, Hiromasa, Noji, Yoshihiro, Yamaguchi, Masato, Fujino, Susumu. Venous Thromboembolism in Japanese Patients With Pancreatic Cancer. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, vol.27, 10760296211051766-.
Yoon, Seug Yun, Lee, Min-Young, Yoon, Jina, Kim, Han Jo, Kim, Kyoung-Ha, Kim, Se Hyung, Lee, Sang-Cheol, Bae, Sang Byung, Kim, Chan-Kyu, Lee, Nam-Su, Lee, Kyu Taek, Park, Sung Kyu, Hong, Dae Sik, Won, Jong-Ho. The incidence of venous thromboembolism is not lowin Korean patients with advanced pancreatic cancer. Blood research, vol.53, no.3, 227-232.
Chen, Jen-Shi, Hung, Chia-Yen, Chang, Hung, Liu, Chien-Ting, Chen, Yen-Yang, Lu, Chang-Hsien, Chang, Pei-Hung, Hung, Yu-Shin, Chou, Wen-Chi. Venous Thromboembolism in Asian Patients with Pancreatic Cancer Following Palliative Chemotherapy: Low Incidence but a Negative Prognosticator for Those with Early Onset. Cancers, vol.10, no.12, 501-.
Lee, Jong-Chan, Ro, Young Sun, Cho, Junhyeon, Park, Yohan, Lee, Ji Hye, Hwang, Jin-Hyeok, Choi, Hye Jin, Lee, Soohyeon. Characteristics of Venous Thromboembolism in Pancreatic Adenocarcinoma in East Asian Ethnics : A Large Population-Based Observational Study. Medicine, vol.95, no.17, e3472-.
Oh, S.Y., Kim, J.H., Lee, K.W., Bang, S.M., Hwang, J.H., Oh, D., Lee, J.S.. Venous thromboembolism in patients with pancreatic adenocarcinoma: Lower incidence in Asian ethnicity. Thrombosis research, vol.122, no.4, 485-490.
Yamai, Takuo, Ikezawa, Kenji, Hiraga, Erika, Kawamoto, Yasuharu, Hirao, Takeru, Higashi, Sena, Daiku, Kazuma, Maeda, Shingo, Abe, Yutaro, Urabe, Makiko, Kai, Yugo, Takada, Ryoji, Nakabori, Tasuku, Fukutake, Nobuyasu, Uehara, Hiroyuki, Fujita, Masashi, Ohkawa, Kazuyoshi. Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel. PLoS ONE, vol.17, no.3, e0264653-.
Pancreatic Adenocarcionma (Version 1. 2022). 2022 [Internet]. Plymouth Meeting (PA): National Comprehensive Cancer Network; 2022 [cited 2022 Nov 2]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf.
Khorana, Alok A., Kuderer, Nicole M., Culakova, Eva, Lyman, Gary H., Francis, Charles W.. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood, vol.111, no.10, 4902-4907.
CME Exam 4: Incidence of Venous Thromboembolism in Patients with Newly Diagnosed Pancreatic Cancer and Factors Associated with Outcomes. Gastroenterology, vol.158, no.5, e19-e19.
Hisada, Yohei, Mackman, Nigel. Cancer-associated pathways and biomarkers of venous thrombosis. Blood, vol.130, no.13, 1499-1506.
Mattila, N., Hisada, Y., Przybyla, B., Posma, J., Jouppila, A., Haglund, C., Seppänen, H., Mackman, N., Lassila, R.. Levels of the cancer biomarker CA 19-9 are associated with thrombin generation in plasma from treatment-naïve pancreatic cancer patients. Thrombosis research, vol.199, 21-31.
Hanna, Kamil, Khalid, Aizaz, Hamidi, Mohammad, Gries, Lynn, Haddadin, Zaid, Kulvatunyou, Narong, Zeeshan, Muhammad, Joseph, Bellal. Chronic Alcohol Consumption and Risk of Deep Venous Thrombosis: A Propensity-Matched Analysis. The Journal of surgical research, vol.244, 251-256.
Pomp, Elisabeth R, Rosendaal, Frits R, Doggen, Carine J. M. Alcohol consumption is associated with a decreased risk of venous thrombosis. Thrombosis and haemostasis, vol.99, no.1, 59-63.
Gaborit, Freja, Overvad, Kim, Nørgaard, Mette, Kristensen, Søren, Tjønneland, Anne, Severinsen, Marianne. Alcohol intake and risk of venous thromboembolism : A Danish follow-up study. Thrombosis and haemostasis, vol.110, no.1, 39-45.
Mukamal, Kenneth J., Jadhav, Praveen P., D’Agostino, Ralph B., Massaro, Joseph M., Mittleman, Murray A., Lipinska, Izabella, Sutherland, Patrice A., Matheney, Travis, Levy, Daniel, Wilson, Peter W.F., Ellison, R. Curtis, Silbershatz, Halit, Muller, James E., Tofler, Geoffrey H.. Alcohol Consumption and Hemostatic Factors : Analysis of the Framingham Offspring Cohort. Circulation, vol.104, no.12, 1367-1373.
Ouaissi, M., Frasconi, C., Mege, D., Panicot-dubois, L., Boiron, L., Dahan, L., Debourdeau, P., Dubois, C., Farge, D., Sielezneff, I.. Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma. Hepatobiliary & pancreatic diseases international : HBPD INT, vol.14, no.4, 436-442.
Conroy, Thierry, Desseigne, Françoise, Ychou, Marc, Bouché, Olivier, Guimbaud, Rosine, Bécouarn, Yves, Adenis, Antoine, Raoul, Jean-Luc, Gourgou-Bourgade, Sophie, de la Fouchardière, Christelle, Bennouna, Jaafar, Bachet, Jean-Baptiste, Khemissa-Akouz, Faiza, Péré-Vergé, Denis, Delbaldo, Catherine, Assenat, Eric, Chauffert, Bruno, Michel, Pierre, Montoto-Grillot, Christine, Ducreux, Michel. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer. The New England journal of medicine, vol.364, no.19, 1817-1825.
Kwon, Hyuk-Chan, Oh, Sung Yong, Lee, Suee, Kim, Sung-Hyun, Han, Jin Yeong, Koh, Ri Young, Kim, Min Chan, Kim, Hyo-Jin. Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients.. Japanese journal of clinical oncology, vol.38, no.1, 2-7.
Wang, Xue-Ping, Mao, Min- Jie, He, Zhong-Lian, Zhang, Lin, Chi, Pei-Dong, Su, Jia-rui, Dai, Shu-Qin, Liu, Wan-Li. A retrospective discussion of the prognostic value of combining prothrombin time(PT) and fibrinogen(Fbg) in patients with Hepatocellular carcinoma. Journal of Cancer, vol.8, no.11, 2079-2087.
Pelzer, Uwe, Opitz, Bernhard, Deutschinoff, Gerd, Stauch, Martina, Reitzig, Peter C., Hahnfeld, Sabine, Müller, Lothar, Grunewald, Martina, Stieler, Jens M., Sinn, Marianne, Denecke, Timm, Bischoff, Sven, Oettle, Helmut, Dörken, Bernd, Riess, Hanno. Efficacy of Prophylactic Low–Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.33, no.18, 2028-2034.
Maraveyas, A., Waters, J., Roy, R., Fyfe, D., Propper, D., Lofts, F., Sgouros, J., Gardiner, E., Wedgwood, K., Ettelaie, C., Bozas, G.. Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer. European journal of cancer, vol.48, no.9, 1283-1292.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.